As 15 of the 104 included MR genes exhibited the significant dysregulation of mRNA expression in IBD, we focused on these genes for our downstream analysis; their differential expression between inflamed and non-inflamed regions in UC and CD is shown in Figure 2A. This evidence concerns the gene NR3C2 and inflammatory bowel disease.